Clinical

Dataset Information

0

Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases


ABSTRACT: The purpose of the study is to evaluate the efficacy and safety of the combination of Panitumumab with FOLFOX 4 Chemotherapy or Panitumumab with FOLFIRI Chemotherapy in Subjects with Wild- Type KRAS Colorectal Cancer and liver-only Metastases.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic,Pacientes Con Cáncer Colorrectal Con Kras No Mutado Y Metástasis Sólo Hepáticas.

PROVIDER: 2071139 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2016-05-05 | E-MTAB-3548 | biostudies-arrayexpress
| 2076606 | ecrin-mdr-crc
| 2109056 | ecrin-mdr-crc
| 2179129 | ecrin-mdr-crc
2019-01-23 | GSE102995 | GEO
2018-11-01 | GSE75090 | GEO
2023-07-20 | PXD042136 | Pride
2012-01-01 | E-GEOD-32048 | biostudies-arrayexpress
2023-12-11 | GSE245560 | GEO
2023-12-11 | GSE245819 | GEO